. Lecanemab Phase 3 Clarity Ad Trial : Aria With the Use of Antiplatelets or Anticoagulants in Early Alzheimer's Disease. Meeting Abstract, International Conference on Alzheimer’s and Parkinson’s Diseases.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.